Mallinckrodt suspends plans for generic drug spinoff

//Mallinckrodt suspends plans for generic drug spinoff

Mallinckrodt suspends plans for generic drug spinoff

Mallinckrodt PLC is suspending plans to spin off its generic products division. The company, which is headquartered in Ireland and has its U.S. base in St. Louis, cited unfavorable market conditions and "increasing uncertainties created by the opioid litigation," the company said Tuesday in its second-quarter financial release. Mallinckrodt and other manufacturers of opioids are facing lawsuits alleging they contributed to the nation's addiction crisis. The Wall Street Journal reported that the…

Article by [author-name] (c) Manufacturing News - Manufacturing News Headlines | Bizjournals.com - Read full story here.

By | 2019-08-07T21:34:08+00:00 August 7th, 2019|Budget and Tax|

About the Author: